TSX News -
Helix Biopharma Corp. Signs Binding Letter of Intent for Development of New CAR-T Technologies
RICHMOND HILL, ONTARIO–(Marketwired – Jan. 4, 2018) – Helix BioPharma Corp. (TSX:HBP)(FRANKFURT:HBP) (“Helix” or the “Company”), an immuno-oncology [...]